clopidogrel

Generic: clopidogrel bisulfate

Labeler: ascend laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clopidogrel
Generic Name clopidogrel bisulfate
Labeler ascend laboratories, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

clopidogrel bisulfate 75 mg/1

Manufacturer
Ascend Laboratories, LLC

Identifiers & Regulatory

Product NDC 67877-276
Product ID 67877-276_04c45152-3a50-45e1-9edb-2ddf3ed43988
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203632
Listing Expiration 2026-12-31
Marketing Start 2024-05-16

Pharmacologic Class

Classes
cytochrome p450 2c8 inhibitors [moa] decreased platelet aggregation [pe] p2y12 platelet inhibitor [epc] p2y12 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 67877276
Hyphenated Format 67877-276

Supplemental Identifiers

RxCUI
309362
UNII
08I79HTP27

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clopidogrel (source: ndc)
Generic Name clopidogrel bisulfate (source: ndc)
Application Number ANDA203632 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 75 mg/1
source: ndc
Packaging
  • 500 TABLET in 1 BOTTLE (67877-276-05)
  • 30 TABLET in 1 BOTTLE (67877-276-30)
  • 90 TABLET in 1 BOTTLE (67877-276-90)
source: ndc

Packages (3)

Ingredients (1)

clopidogrel bisulfate (75 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "04c45152-3a50-45e1-9edb-2ddf3ed43988", "openfda": {"unii": ["08I79HTP27"], "rxcui": ["309362"], "spl_set_id": ["db1161c9-6efd-4361-a766-6a37c241ccee"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (67877-276-05)", "package_ndc": "67877-276-05", "marketing_start_date": "20240516"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (67877-276-30)", "package_ndc": "67877-276-30", "marketing_start_date": "20240516"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (67877-276-90)", "package_ndc": "67877-276-90", "marketing_start_date": "20240516"}], "brand_name": "CLOPIDOGREL", "product_id": "67877-276_04c45152-3a50-45e1-9edb-2ddf3ed43988", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "67877-276", "generic_name": "CLOPIDOGREL BISULFATE", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CLOPIDOGREL", "active_ingredients": [{"name": "CLOPIDOGREL BISULFATE", "strength": "75 mg/1"}], "application_number": "ANDA203632", "marketing_category": "ANDA", "marketing_start_date": "20240516", "listing_expiration_date": "20261231"}